Literature DB >> 24915878

Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease.

Mykhaylo S Frasinyuk1, Stefan Kwiatkowski2, Jonathan M Wagner3, Timothy J Evans3, Robert W Reed3, Konstantin V Korotkov3, David S Watt4.   

Abstract

Mycosin protease-1 (MycP1) cleaves ESX secretion-associated protein B (EspB) that is a virulence factor of Mycobacterium tuberculosis, and accommodates an octapeptide, AVKAASLG, as a short peptide substrate. Because peptidoboronic acids are known inhibitors of serine proteases, the synthesis and binding of a boronic acid analog of the pentapeptide cleavage product, AVKAA, was studied using MycP1 variants from Mycobacterium thermoresistible (MycP1mth), Mycobacterium smegmatis (MycP1msm) and M. tuberculosis (MycP1mtu). We synthesized the boropentapeptide, HAlaValLysAlaAlaB(OH)2 (1) and the analogous pinanediol PD-protected HAlaValLysAlaAlaBO2(PD) (2) using an Fmoc/Boc peptide strategy. The pinanediol boropentapeptide 2 displayed IC50 values 121.6±25.3 μM for MycP1mth, 93.2±37.3 μM for MycP1msm and 37.9±5.2 μM for MycP1mtu. Such relatively strong binding creates a chance for crystalizing the complex with 2 and finding the structure of the unknown MycP1 catalytic site that would potentially facilitate the development of new anti-tuberculosis drugs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Boronic acid; Inhibitor; Pentapeptide; Protease

Mesh:

Substances:

Year:  2014        PMID: 24915878      PMCID: PMC4120117          DOI: 10.1016/j.bmcl.2014.05.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Understanding specificity of the mycosin proteases in ESX/type VII secretion by structural and functional analysis.

Authors:  Jonathan M Wagner; Timothy J Evans; Jing Chen; Haining Zhu; Edith N G Houben; Wilbert Bitter; Konstantin V Korotkov
Journal:  J Struct Biol       Date:  2013-10-07       Impact factor: 2.867

2.  Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system.

Authors:  Sarah A Stanley; Sridharan Raghavan; William W Hwang; Jeffery S Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

3.  Distinct specificities of Mycobacterium tuberculosis and mammalian proteasomes for N-acetyl tripeptide substrates.

Authors:  Gang Lin; Christopher Tsu; Lawrence Dick; Xi K Zhou; Carl Nathan
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

Review 4.  Development of the proteasome inhibitor Velcade (Bortezomib).

Authors:  Julian Adams; Michael Kauffman
Journal:  Cancer Invest       Date:  2004       Impact factor: 2.176

5.  Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen.

Authors:  Aaron M LeBeau; Pratap Singh; John T Isaacs; Samuel R Denmeade
Journal:  Chem Biol       Date:  2008-07-21

6.  Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes.

Authors:  W W Bachovchin; W Y Wong; S Farr-Jones; A B Shenvi; C A Kettner
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.162

7.  Synthesis and antimicrobial activity of α-aminoboronic-containing peptidomimetics.

Authors:  Olga V Gozhina; John Sigurd Svendsen; Tore Lejon
Journal:  J Pept Sci       Date:  2013-11-13       Impact factor: 1.905

8.  Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid.

Authors:  R Bone; A B Shenvi; C A Kettner; D A Agard
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

Review 9.  Targeting type VII/ESX secretion systems for development of novel antimycobacterial drugs.

Authors:  Daria Bottai; Agnese Serafini; Alessandro Cascioferro; Roland Brosch; Riccardo Manganelli
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Novel mycosin protease MycP₁ inhibitors identified by virtual screening and 4D fingerprints.

Authors:  Adel Hamza; Jonathan M Wagner; Timothy J Evans; Mykhaylo S Frasinyuk; Stefan Kwiatkowski; Chang-Guo Zhan; David S Watt; Konstantin V Korotkov
Journal:  J Chem Inf Model       Date:  2014-03-27       Impact factor: 4.956

View more
  3 in total

1.  Expression and production of soluble Mycobacterium tuberculosis H37Rv mycosin-3.

Authors:  Zhuo Fang; Wolf-Dieter Schubert; Nicolaas Claudius Gey van Pittius
Journal:  Biochem Biophys Rep       Date:  2016-02-06

2.  AntiTbPdb: a knowledgebase of anti-tubercular peptides.

Authors:  Salman Sadullah Usmani; Rajesh Kumar; Vinod Kumar; Sandeep Singh; Gajendra P S Raghava
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

3.  Inhibitors of Mycobacterium marinum virulence identified in a Dictyostelium discoideum host model.

Authors:  Hajer Ouertatani-Sakouhi; Sébastien Kicka; Gianpaolo Chiriano; Christopher F Harrison; Hubert Hilbi; Leonardo Scapozza; Thierry Soldati; Pierre Cosson
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.